Viveve Medical, Inc. (VIVE) Financials

VIVE Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2022 12.2 million 11.0 million
June 30, 2022 15.5 million 10.2 million
March 31, 2022 20.7 million 10.5 million
Dec. 31, 2021 25.9 million 10.8 million

VIVE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2022 -3.5 million 868000
June 30, 2022 -4.6 million 909000
March 31, 2022 -5.1 million 960000
Dec. 31, 2021 -3.5 million 1.0 million

VIVE Net Income

No data available :(

VIVE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2022 5.9 million - 253000
June 30, 2022 9.4 million - 244000
March 31, 2022 14.0 million - 234000
Dec. 31, 2021 19.2 million - 225000

VIVE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2022 10.7 million
June 30, 2022 10.6 million
March 31, 2022 10.6 million
Dec. 31, 2021 10.1 million

VIVE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2022 193000 1.8 million 3.4 million -
June 30, 2022 59000 1.9 million 3.4 million -
March 31, 2022 49000 2.1 million 3.7 million -
Dec. 31, 2021 294000 2.9 million 3.1 million -

VIVE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2022 1.7 million 1.1 million
June 30, 2022 1.8 million 1.5 million
March 31, 2022 1.6 million 1.3 million
Dec. 31, 2021 1.7 million 1.7 million

VIVE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VIVE

Price: $0

52 week price:
0.00
0.22

Earnings Per Share: -2.65 USD

Exchange: OEM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 104883

Ebitda: -8.7 million

Market Capitalization: 3217

Links: